| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | China | 3 | |
| #3 | United States | 2 | |
| #4 | Hong Kong | 1 | |
| #5 | Mexico | 1 | |
| #6 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks | |
| #5 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Analysing materials | |
| #6 | Enzymes | |
| #7 | Measuring microorganism processes | |
| #8 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nakatsuru Shuichi | 8 |
| #2 | Ikuta Yoshiaki | 6 |
| #3 | Nishimura Yasuharu | 6 |
| #4 | Nakamura Yusuke | 5 |
| #5 | Tsunoda Takuya | 3 |
| #6 | Watanabe Tomohisa | 2 |
| #7 | Daigo Yataro | 2 |
| #8 | Osawa Ryuji | 2 |
| #9 | Yoshimura Sachiko | 2 |
| #10 | Huntley Raymond | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN105418751A | Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same | |
| EP1812796A1 | Pkp3 oncogene as a prognostic indicator for lung adenocarcinoma |